Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease.
Pitkänen N, Finkenstedt A, Lamina C, Juonala M, Kähönen M, Mäkelä KM, Dieplinger B, Viveiros A, Melmer A, Leitner I, Kedenko L, Seppälä I, Viikari JSA, Mueller T, Kronenberg F, Paulweber B, Lehtimäki T, Zoller H, Raitakari OT, Dieplinger H.
Pitkänen N, et al. Among authors: leitner i.
Clin Chem Lab Med. 2021 Dec 2;60(2):243-251. doi: 10.1515/cclm-2021-0837. Print 2022 Jan 27.
Clin Chem Lab Med. 2021.
PMID: 34850615
Free article.